TITLE

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease

AUTHOR(S)
M.N. Choudhry; H. Soran; H.M. Ziglam
PUB. DATE
June 2008
SOURCE
QJM: An International Journal of Medicine;Jun2008, Vol. 101 Issue 6, p445
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Clostridium difficile is the most common infectious cause of colitis and has been increasingly diagnosed in hospitalized patients. The number of prescriptions for proton pump inhibitors (PPIs) has also increased significantly over time. Few studies have reported an association between C. difficile-associated disease (CDAD) and PPI use. Aim: To assess the extent and appropriateness of PPI prescribing in patients diagnosed with C. difficile infection. Methods: We prospectively studied PPI prescriptions in 138 hospitalized patients diagnosed with C. difficile infection over a 4-month period. Clostridium difficile infections were diagnosed by the presence of C. difficile toxin in the stools. The appropriateness of prescriptions and relevant investigations were assessed by interview of patients and review of patient records. Results: Sixty-four percent (88 of 138) of all patients who developed C. difficile infections were on PPIs. A valid indication for PPIs therapy was not apparent in 63% of the patients. Conclusion: There appears to be a widespread and inappropriate use of PPIs in hospital practice. Reduction of unnecessary PPIs use may be an additional strategy to reduce the incidence of this infection.
ACCESSION #
33044655

 

Related Articles

  • Clostridium difficile in the Pediatric Population of Monroe County, New York. Rhee, Susan M.; Tsay, Rebecca; Nelson, Deborah S.; van Wijngaarden, Edwin; Dumyati, Ghinwa // Journal of the Pediatric Infectious Diseases Society;Sep2014, Vol. 3 Issue 3, p183 

    Background Clostridium difficile infection (CDI) incidence in hospitalized children has increased over the past decade and disease has been reported in the community. Therefore, population surveillance that includes nonhospitalized cases is important to accurately estimate the burden of CDI in...

  • Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. Werner, Nicole L.; Hecker, Michelle T.; Sethi, Ajay K.; Donskey, Curtis J. // BMC Infectious Diseases;2011, Vol. 11 Issue 1, p187 

    Background: Fluoroquinolones are among the most commonly prescribed antimicrobials and are an important risk factor for colonization and infection with fluoroquinolone-resistant gram-negative bacilli and for Clostridium difficile infection (CDI). In this study, our aim was to determine current...

  • CLOSTRIDIUM DIFFICILE COLITIS: OPTIMIZING A COST-EFFECTIVE APPROACH. Surawicz, Christina; Johnson, David // American Journal of Gastroenterology;Aug1996, Vol. 91 Issue 8, p1662 

    Comments on a study of hospitalized patients whose stool samples had been sent for Clostridium difficile toxin assay. Information on Clostridium difficile; Significance of the study to clinicians; Details of experimental procedures and results.

  • C. difficile screening can be cost effective in US hospitals.  // PharmacoEconomics & Outcomes News;8/4/2012, Issue 659, p3 

    The article discusses the results of a research study on the cost-effectiveness of screening hospital patients in the U.S. for Clostridium difficile.

  • Hypervirulent Clostridium difficile Strains in Hospitalized Patients, Canada. Mulvey, Michael R.; Boyd, David A.; Gravel, Denise; Hutchinson, Jim; Kelly, Sharon; McGeer, Allison; Moore, Dorothy; Simor, Andrew; Suh, Kathryn N.; Taylor, Geoff; Weese, J. Scott; Miller, Mark // Emerging Infectious Diseases;Apr2010, Vol. 16 Issue 4, p678 

    The article discusses research which was conducted in an effort to investigate the incidence rate of infections with North American pulsed-field types 7 and 8 (NAP7/NAP8) strains of Clostrodium difficile, ribotype 078, and toxinotype V strains of Clostrodium difficile in hospitalized patients in...

  • Mortality related to C. difficile 2.5 times higher than controls. Shafer, Emily // Hem/Onc Today;10/10/2012, Vol. 13 Issue 19, p22 

    The article discusses research being done on the mortality rate among hospitalized patients with Clostridium difficile infection.

  • Hospital acquired infection. Starr, John // BMJ: British Medical Journal (International Edition);4/7/2007, Vol. 334 Issue 7596, p708 

    The article presents an editorial about hospital acquired infections. The prevalence of methicillin resistant Staphylococcus aureus bacteremia and Clostridium difficile infections in hospital patients is discussed. Control measures against the spread of Clostridium difficile infections in...

  • Risk Factors for Relapse and Mortality of Clostridium Difficile-Associated Diarrhea. Arsic, Bogdan; Pavlovic, Momcilo; Berenji, Karolina // Macedonian Journal of Medical Sciences;Jun 2014, Vol. 7 Issue 2, p249 

    AIM: The aim of the present paper was to identify prognostic factors for relapse and mortality in patients with hospital-acquired infections caused by Clostridium difficile. MATERIAL AND METHODS: This study included 133 patients with healthcare facility-associated disease caused by C. difficile....

  • NHS Trust admits 'mistakes were made'  // British Journal of Community Nursing;Dec2009 Supplement, Vol. 14, pS29 

    The article reports on the decision of Leeds Hospital NHS Trust to admit its responsibility in the death of its patient, Kenneth Ballinger, on June 13, 2006, and provide damage compensation to his family in an out-of-court settlement. Ballinger was admitted to the hospital after a fall at home...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics